The European medicines regulator said on Friday it will review safety information for Eisai and Biogen's Leqembi, nearly ...

New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...

A delay in getting to the rapid eye movement (REM) stage of sleep may be linked to Alzheimer's disease and related dementias, ...

European Union regulators will review new information relating to the safety of Eisai Co.’s and Biogen Inc.’s medicine for ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...

Groundbreaking study uncovers the crucial link between REM sleep patterns and Alzheimer's disease, providing new insights for ...

However, some research suggests that poor sleep could raise your risk of Alzheimer’s. A study published in November found ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...

Keeping active throughout life – particularly before the age of 50 – leads to changes in the brain that could help stave off dementia, according to a study.Researchers suggest this could be down to ...

Delays in dreaming might be an early warning sign of Alzheimer's disease. People who take significantly longer to enter the ...

Alzheimer’s affects millions of Americans and can have a devastating impact on finances. Some of the worst damage is done before a diagnosis is even made.

The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...